Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
10.57
+0.53 (5.28%)
At close: Aug 15, 2025, 4:00 PM
10.25
-0.32 (-3.03%)
After-hours: Aug 15, 2025, 7:19 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $557.08 million as of August 15, 2025. Its market cap has increased by 265.45% in one year.
Market Cap
557.08M
Enterprise Value
518.13M
1-Year Change
265.45%
Ranking
Category
Stock Price
$10.57
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $557.08M, an increase of 55.77%. That is a compound annual growth rate of 6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 557.08M | 6.64% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 606.42B |
| Johnson & Johnson | 420.30B |
| AbbVie | 361.30B |
| UnitedHealth Group | 243.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.14B |